Commentary
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
Acute kidney injury (AKI) is common in hospitalized patients and is associated with high morbidity and mortality, especially if requiring renal replacement therapy. Continuous renal replacement therapy (CRRT) is indicated in patients who are
[read more...]Women of reproductive age with chronic kidney disease (CKD) who desire to have children face potential complications during pregnancy. Today we will use a recent AJKD perspective, “Women’s Reproductive Health for the Nephrologist,” in addition
[read more...]Overview of Metabolic Acidosis in CKD The presence of a mildly diminished bicarbonate in advanced chronic kidney disease (CKD) is one of the more polarizing topics in nephrology. Some would argue that the impaired acid-base homeostasis will lead
[read more...]When I was a medical resident, a novel developmental therapy for the treatment of certain cancers was to medically shut off the blood supply and cause ischemia to the mass. Avastin (bevacizumab), or anti-VEGF (vascular endothelial growth factor)
[read more...]Intradialytic hypotension (IDH) is sometimes defined as a decrease in systolic BP by ≥20 mm Hg or a decrease in mean arterial pressure of 10 mm Hg associated with symptoms. There are, however, other definitions of IDH in the literature. Whereas
[read more...]In the United States, approximately 37 million people in the United States have chronic kidney disease (CKD), and in 2016, there were more than 720,000 patients with ESRD on various renal replacement therapies (hemodialysis, peritoneal dialysis, or
[read more...]Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury on light microscopy that is characterized by mesangial expansion with hypercellularity, endocapillary proliferation, and double-contour formation along the glomerular
[read more...]The identification of APOL1-related kidney disease and recognition of its large contribution to excess risk of end-stage kidney disease (ESKD) in people of West African origin has been one of the biggest stories in nephrology over the past 2 decades
[read more...]There has been significant interest in SGLT2 inhibitors (SGLT2i) as novel oral anti-hyperglycemic agents that have been recently approved for the treatment of type 2 diabetes mellitus (T2DM). Studies such as CANVAS allude to their glucose-lowering
[read more...]Shared decision-making, an approach in which clinicians and patients partner to evaluate best available evidence for treatment options, discuss risks and benefits, and make informed decisions that align with goals and values, is a central tenet of
[read more...]
